home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  

registry of biomedical companies

  May 28, 2024
promoting the transfer of scientific know-how between industry and academia
Registry of biomedical companies:

[3] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 461 active entries

Retroscreen Virology Ltd.

Centre for Infectious Diseases, Bart's & The Londo
London, E1 4NS
United Kingdom

Phone: +44 (0) 20 8882 7966
Fax: +44 (0) 20 8882 6990

Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.


Retroscreen Virology is Europe’s leading contract virology research company, created in 1989 from St Bartholomew’s and the Royal London Hospital by Professor John Oxford, world renowned influenza virologist.

The work we conduct is dedicated to creating the next generation of Antivirals and Vaccines in the field of biomedical research.

Our research projects include in vitro developments of novel compounds against the following viruses; this also includes influenza in vivo models:

  • Influenza A
  • Influenza B
  • Avian Influenza A
  • Rhinovirus (HRV)
  • Human Coronavirus
  • Human Adenovirus
  • Parainfluenza
  • Respiratory Syncytial Virus (RSV)
  • Human Rotavirus
  • Human Immunodeficiency Virus (HIV-1)
  • Hepatitis C Virus (in development)
  • Urbani SARS Virus
  • Herpes Simplex Virus (HSV-1; HSV-2)
  • Modified Vaccinia Ankara
  • West Nile Virus (in development)
  • Human Papillomavirus
  • Dengue virus (in development)

Retroscreen Virology is accredited to Good Laboratory Practice (GLP) and conducts all clinical studies to the regulations of Good Clinical Practice (GCP)/ICH guidelines.

We are the only company in the UK that are able to conduct human influenza challenge studies in a specialised quarantine unit with A/Panama/2007/99 and A/New Caledonia/20/99 viruses and have characterised influenza A (H1N1 and H3N2) and B viruses.

We have recently cultivated the SARS virus in our containment laboratory and investigated virucides and lozenges for major pharmaceutical companies.

We have excellent facilities in our category II and III laboratories and clinic, and a first-rate team of intelligent scientific researchers, doctors, and nurses.

Please contact us via our website at www.retroscreen.com

Selected Categories:

Product Company   Service Company
- General
- Research
- General
- Research
- Research
- Services

Last update of this entry: July 13, 2004

home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2024 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.